bapineuzumab News
Most Popular bapineuzumab Story
Elan deal rumors fly; investors not enthused
No sooner did Elan announce that it was evaluating its "strategic alternatives" than rumors began moving markets. The Danish pharma Lundbeck quickly arose as a possible suitor, on the flimsy evidence... Read more...
Latest Headlines
- September 29, 2009
- July 2, 2009
- January 20, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
